Proposed terms provide for upfront payments, clinical development milestone and commercial milestone payments to TFF Pharmaceuticals of up to $281 million, as well as negotiated royalty payments Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback